SCHEMBL7142587

SCHEMBL7142587

CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)c1ccc(-c2ccco2)cc1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 5/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7612229 0.95 NLRP3 (0.61) NLRP3
SCHEMBL7135760 0.89 NLRP3 (0.66) NLRP3
SCHEMBL24478590 0.78 NLRP3 (0.74) NLRP3
SCHEMBL19519055 0.77 NLRP3 (0.73) NLRP3
SCHEMBL7143556 0.74 NLRP3 (0.77) NLRP3
SCHEMBL20636461 0.74 NLRP3 (0.68) NLRP3
SCHEMBL20636034 0.73 NLRP3 (0.70) NLRP3
SCHEMBL7140501 0.73 NLRP3 (0.75) NLRP3
SCHEMBL7566889 0.72 NLRP3 (0.65) NLRP3
SCHEMBL7146088 0.72 NLRP3 (0.73) NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed